
TherapeuticsMD Inc (NASDAQ:TXMD) shares are surging Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners.
EW Healthcare Partners will commence a tender offer to acquire all outstanding shares of TherapeuticsMD common stock for $10 per share in an all-cash transaction, which will be followed immediately by a merger under the terms of the transaction. The transaction implies a total enterprise value of approximately $177 million.